Segments (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended			9 Months Ended
	Sep. 30, 2013		Sep. 30, 2012	Sep. 30, 2013		Sep. 30, 2012	Dec. 31, 2012
Segment Reporting Information [Line Items]
Product revenues	$ 16,563		$ 11,495	$ 50,708		$ 30,051
Revenue from services	2,770		100	9,050		332
Revenue from transfer of intellectual property	1,308		200	16,080		400
Operating (loss) income	(19,010)		(9,369)	(43,766)		(27,557)
Depreciation and amortization	3,768		2,665	10,648		7,447
Total revenues	20,641		11,795	75,838		30,783
Assets	1,382,982	[1]		1,382,982	[1]		289,830	[1]
Goodwill	222,340	[1]		222,340	[1]		80,450	[1]
United States [Member]
Segment Reporting Information [Line Items]
Total revenues	4,078		300	25,130		732
Chile [Member]
Segment Reporting Information [Line Items]
Total revenues	7,993		6,781	24,216		19,669
Spain [Member]
Segment Reporting Information [Line Items]
Total revenues	4,026		1,997	13,503		1,997
Israel [Member]
Segment Reporting Information [Line Items]
Total revenues	3,099		1,516	9,666		4,661
Mexico [Member]
Segment Reporting Information [Line Items]
Total revenues	1,445		1,201	3,323		3,724
Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Product revenues
Revenue from services	60		57	180		159
Revenue from transfer of intellectual property	0		0	0		0
Operating (loss) income	(6,606)		(3,804)	(17,393)		(9,650)
Depreciation and amortization	31		44	121		132
Assets	180,598			180,598			35,109
Goodwill
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Operating (loss) income	(879)		0	(2,419)		0
Pharmaceutical [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Product revenues	16,563		11,495	50,708		30,051
Revenue from services	0		0	0		0
Revenue from transfer of intellectual property	913		0	14,720		0
Operating (loss) income	(11,126)		(1,755)	(7,171)		(5,072)
Depreciation and amortization	2,020		1,780	5,417		4,805
Assets	1,087,950			1,087,950			142,299
Goodwill	174,734			174,734			32,844
Diagnostics [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Product revenues
Revenue from services	2,710		43	8,870		173
Revenue from transfer of intellectual property	395		200	1,360		400
Operating (loss) income	(399)		(3,810)	(16,783)		(12,835)
Depreciation and amortization	1,717		841	5,110		2,510
Assets	114,434			114,434			112,422
Goodwill	$ 47,606			$ 47,606			$ 47,606

[1] As of September 30, 2013 and December 31, 2012, total assets include $5.9 million and $5.6 million, respectively, and total liabilities include $8.7 million and $5.5 million, respectively related to SciVac Ltd ("SciVac"), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.